|
Not all equine treatments are created equal Many treatments are sold to relieve the symptoms of degenerative joint disease. However, not all products are supported by solid scientific research or manufactured under approval by the U.S. Food and Drug Administration. Those include injectable chondroitin sulfate, pharmacy-compounded injectable glucosamine, and oral products claiming to be sulfated glycosaminoglycans. Studies of non-FDA approved products and oral nutritional supplements have shown significantly less effectiveness than products with FDA approval. Generic products also require FDA approval since generic drugs are chemical copies of approved drugs that no longer have patent protection. No approved generic forms of Adequan® i.m. for horses (polysulfated glycosaminoglycan) are currently available. Ask your veterinarian for FDA-approved Adequan® i.m. for equines (polysulfated glycosaminoglycan) If your horse exhibits heat, pain or swelling, stiffness or decreased performance, you should immediately consult your equine veterinarian.
Early recognition and treatment can limit the damage and restore the normal “wear and repair” balance in the joints before permanent cartilage or bone damage occurs. Non-infectious arthritis, also known as degenerative joint disease, is estimated to cause one-third of all lameness cases. Adequan® i.m. for horses (polysulfated glycosaminoglycan) is the only disease-modifying osteoarthritis drug on the market approved by the FDA for the treatment of equine arthritis. It is the only joint therapy clinically proven to relieve symptoms and treat the underlying causes of equine degenerative joint disease. After six weeks of comparison to intravenous Legend® (intravenous sodium hyaluronate), Adequan® i.m. for equines demonstrated, on average, a more rapid and significantly better recovery: • Decreased lameness score
• Increased stride length
• Lowered joint flexing pain score Studies have not been conducted to establish safety in breeding horses. Do not use in horses intended for human consumption.
Last update : 05-03-2008 06:44
|
(0 vote)